Innovative Biochemical Analysis Solutions
If you used Z Biotech’s glycan and glycan array products and services in your research and cited in the publications please send a copy or link of the publication to us. In order to express our appreciation the author(s) will receive a gift from us.
Qi Long Lu, MD, PhD.
Scientific Advisory Board
Jian Zhang, PhD.
Founder and CEO
Ms. Kelly has her bachelor’s degree in chemistry with emphasis in biochemistry. After working at Z Biotech as the primary lab technician for over a year she has developed a deeper understanding of biochemistry, carbohydrate and microarray as well as scrupulous technical skills. Along with her foundation in biochemistry, she also applies aptitude in writing and design to contribute to Z Biotech’s research, scientific writing, and marketing. Ms. Kelly’s experience and creative yet pragmatic scientific approach makes her an asset to our research and development of microarray technology.
Dr. Zhang earned his Doctorate degree in Bioorganic Chemistry from Shanghai Institute of Organic Chemistry (SIOC), Chinese Academy of Science. From 2005 to 2012, he held various academic and industrial positions from carbohydrate synthesis to microarray development. He is an experienced biomedical research scientist and principal investigator and has been awarded more than 1.8 million Small Business Innovative Research (SBIR) grants. In 2013, Dr. Zhang founded Z Biotech, LLC to offer academic and industrial organizations highly advanced glycan microarray products and analytical services. He has great passion to take entrepreneurial initiative, create a new business venture by raising resources, and apply innovative ideas to solve problems and meet the needs of glycoscience market. Dr. Zhang has authored and co-authored more than 20 articles and patents.
Dr. Lu is one of world’s most knowledgeable and respected scientists in Muscular Dystrophy research, and the Director of McColl-Lockwood Laboratory for Muscular Dystrophy Research at Carolinas Medical Center. His main interests are experimental therapy particularly for muscular dystrophies with glycosylation defects.
Dr. Lu’s research focuses are glycan therapy and gene therapy for limb-girdle muscular dystrophy. The aim of one of his research programs is to identify O-mannose α-dystroglycans and their regulation in glycosylation for developing new therapy to the muscular dystrophies. Synthetic α-dystroglycans have the potential to compensate for the defects in protein modification with glycans and improve the functions of dystrophic muscles due to the lack of proper glycans on the surface of specific proteins. Dr. Lu received his PhD from University of London and has authored more than 50 articles and book chapters.